Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
The European regulator will conduct a re-inspection of the facility to verify the compliance
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC), if approved
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Subscribe To Our Newsletter & Stay Updated
_256_384.JPG)
